Navigation Links
Experimental Drug Seems to Aid Memory in Mice With Alzheimer's
Date:5/14/2013

TUESDAY, May 14 (HealthDay News) -- An experimental drug improved the memory and brain function in older mice with advanced symptoms of Alzheimer's disease, according to a new study.

Researchers from the Salk Institute in San Diego found that the drug, known as J147, increased levels of proteins that form the connections responsible for learning and memory, and reduced levels of a protein linked to cell death in the mice.

This explains how treating the mice with J147 led to an increase in factors that are necessary for correct memory function, according to the authors of the study, which was published online May 13 in the journal Alzheimer's Research & Therapy.

The effectiveness of J147 is the result of a new drug-discovery approach developed at the Salk Institute, said David Schubert, who heads the Cellular Neurobiology Laboratory.

"Our approach to screening drugs is very different from that currently used by pharmaceutical companies," Schubert said in a journal news release. "Alzheimer's disease is a complex disease associated with old age, and our goal is to make drugs like J147 that reduce the multiple toxicities associated with the disease, not just one.

"We believe that J147 is the best Alzheimer's disease drug candidate in the pipeline and will be effective if we can get it into the clinic," he added.

The researchers noted that separate studies found that J147 and another drug called donepezil (brand name Aricept) improved short-term memory and another form of memory commonly lost in Alzheimer's patients. They said that only J147 improved spatial memory, which relates to remembering information about places, such as knowing your way around your neighborhood.

Success in animal research is no guarantee of similar results in human research.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.

-- Mary Elizabeth Dallas

SOURCE: BioMed Central, news release, May 13, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mayo Clinic finds experimental drug inhibits growth in all stages of common kidney cancer
2. Experimental Drug for Hepatitis C Promising, Studies Show
3. Experimental Vaccine Shows Promise for Ovarian Cancer
4. Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors
5. Experimental Staph Vaccine Fails to Work, Study Finds
6. Experimental Drug May Work Against Hepatitis C
7. Experimental Alzheimers Drug Shows Promise, Study Finds
8. Experimental Vitiligo Treatment Shows Promise in Mice
9. Harmful effects of bisphenol A proved experimentally
10. Experimental agent briefly eases depression rapidly in test
11. NIH-funded trial launched to assess experimental TB drug
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Drug Seems to Aid Memory in Mice With Alzheimer's
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... Room (ER) on Wednesday, August 16, to community partners. The newly renovated ER ... “Fast Track” area for minor emergencies, eight semi-private rooms to deliver patient results, ...
(Date:8/17/2017)... ... 17, 2017 , ... An August 2 article on NextShark discusses ... largely influenced by the growing popularity of “pretty boys” in both K-Pop and television ... of male appearance are changing not only in the Asian nation, where plastic surgery ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... care professionals, today announced that it has raised $1.675 M in seed funding ... Rethink Education, Lumina Foundation, and Techstars Venture Capital Fund are the company’s primary ...
(Date:8/17/2017)... ... August 17, 2017 , ... Momkus McCluskey Roberts LLC ... Parks is a member of the firm’s Commercial Litigation and Employment Law groups. , ... wealth of knowledge in matters of employment litigation, commercial litigation and business disputes. Her ...
(Date:8/17/2017)... ... 2017 , ... Finalists in the 2017 (second annual) ... awards recognize the world’s best employers and the human resources professionals, teams, achievements ... to work. , A diverse group of organizations and individuals around the world ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
(Date:8/7/2017)... Insightin Health, provider of data-driven decision-making ... announced the selection of Michael Wood ... as of February 2017. In this role, Wood will ... our clients. Wood brings with him more than ... analytics within the healthcare industry. Wood formerly served ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
Breaking Medicine Technology: